Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Catalyst Pharmaceuticals, Inc. (CPRX) Rapidly Approaching Commercialization of Firdapse®

Catalyst Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative therapies for people with rare debilitating diseases. The company’s lead product candidate, Firdapse®, recently completed a pivotal phase III clinical trial for the treatment of Lambert-Eaton myasthenic symdrome (LEMS), a rare neuromuscular, autoimmune disorder that afflicts about 3,000 people in the […]

Latitude 360, Inc. (LATX) Announces Execution of Management Agreements for Two New Locations and Enters LOI to Purchase Three Stores

Today before the opening bell, Latitude 360, Inc., the “ultimate upscale multi-dimensional entertainment eatery,” told investors that it has entered into management agreements for two locations of Revolutions, an upscale bowling, dining & entertainment concept owned by Frank Entertainment. The company intends to later acquire these two stores plus a third location in the near […]

Cherubim Interests, Inc. (CHIT) Taps into New Markets

Cherubim Interests is quickly gaining a foothold in the alternative construction, real estate development and controlled environment agriculture sectors. Not only is this development-stage company focused on alternative construction projects, it also identifies mixed-use, single-family and multi-family properties for the purpose of real estate development, management and investment activities in North America. Within this sphere, […]

ENGlobal Corp. (ENG) Expands Management Team

ENGlobal, a leading provider of automation and engineering services, announced this morning that it has added two key professionals to its management team in newly created positions. The decision to expand its leadership team was made to support the company’s strategic commitment to further strengthen its midstream project execution and automation engineering businesses. Mr. John […]

The Alkaline Water Company, Inc. (WTER) Promoting Financial Growth with Rapidly Expanding Retail Presence

The Alkaline Water Company, Inc. (OTCQB: WTER) produces, distributes, markets and sells bottled alkaline water under the Alkaline88 brand. The company’s product, which is created using a proprietary electrolysis process, is an 8.8 pH-balanced bottled drinking water enhanced with trace minerals and electrolytes and specially formulated to promote a healthy, balanced lifestyle. With regular consumption, […]

International Stem Cell Corp. (ISCO): A Double Threat with Cutting-Edge, Ethically Derived Stem Cell Therapies & Commercial-Scale Biobanking

On the cusp of milestone TGA (Therapeutic Goods Administration) authorization in Australia to start clinical trials in its breakthrough Parkinson’s disease (PD) treatment using human parthenogenetic neural stem cells (hpNSCs), International Stem Cell Corp. (OTCQB: ISCO) was proud to show markets recently that the company has achieved a point of maturity where it is also […]

Jagged Peak, Inc. (JGPK) Records Substantial Financial Growth with Innovative EDGE Technology

Jagged Peak is a leading ecommerce solutions provider with software and services that enhance the scalability, flexibility and profitability of multi-channel online businesses. The company’s cornerstone technology, EDGE, is an enterprise-class ecommerce platform that includes a full-featured ecommerce platform and robust order management system (OMS), as well as a warehouse management system and transportation management […]

 

From Our Blog

Nutriband Inc. (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape

May 9, 2025

A Market Demanding Safer Opioid Solutions The opioid crisis remains a critical public health challenge in the U.S. and globally, prompting a series of new regulatory measures designed to improve safety and reduce misuse. In early 2025, the FDA approved Journavx (suzetrigine), a first-in-class non-opioid painkiller offering patients safer alternatives to opioids. Additionally, opioid manufacturers […]

Rotate your device 90° to view site.